Home
Galixir

Galixir Market Share Analysis for February 2026

星药科技（galixir）成立于2019年，是一家使用尖端人工智能技术赋能药物研发的公司。星药通过使用人工智能的前沿算法，结合计算化学、药物化学和生物学的工具及经验，全方位攻克小分子药物早期研发流程中的疑难问题，快速发现活性高、成药性好且结构新颖的候选分子。

Industry: N/A

Domaingalixir.com

Year Founded2019

Employees51 - 200

Annual Revenue$1M - $2M

Galixir

Galixir (including company regionals)

galixir.com

See more website traffic and engagement information

Galixir Revenue up to February 2026 is 1M - 2M

revenue generated by Galixir top domains

Galixir top domains revenue over 3 years

Revenue for Galixir top domains

galixir.com1M - 2M

See more with Sales Intelligence

Total visits to Galixir's top domains

Understand Galixir market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Galixir's top domains

Analyze Galixir engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Galixir's top domains

See how Galixir keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Galixir top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Galixir

These are the website technologies, by industry, used by Galixir top domains

Advertising (2)

PubMatic

Conversion & Analytics (1)

Baidu Analytics

Mobile (1)

Meta Viewport

News & Signals from Galixir

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDoublerainbowbio partnered with Galixir on Nov 7th '22.Double Rainbow, a sustainable health care company harnessing the power of natural evolution through bioengineering to improve the quality of human health, today announced its partnership with Galixir, a biotech company that drives drug discovery through artificial intelligence.

NewsYfcapital invests into Galixir.Ruiyun Cold Chain has raised 100 million yuan ($15 million) in a pre-A round, while AI drug discovery platform Galixir has completed a new round of financing from Yunfeng Capital, DCM, and others.